Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial

BackgroundPatients with early stage papillary thyroid carcinoma (PTC), are faced with the decision to either to accept or reject adjuvant radioactive iodine (RAI) treatment after thryroidectomy. This decision is often difficult because of conflicting reports of RAI treatment benefit and medical evidence uncertainty due to the lack of long-term randomized controlled trials.MethodsWe report the protocol for a parallel, 2-arm, randomized trial …